CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis

Pharmacogenetics. 1997 Jun;7(3):247-50. doi: 10.1097/00008571-199706000-00010.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aryl Hydrocarbon Hydroxylases*
  • Carcinoma, Hepatocellular / genetics*
  • Cytochrome P-450 CYP2A6
  • Cytochrome P-450 Enzyme System / genetics*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Liver Cirrhosis / genetics*
  • Liver Neoplasms / genetics*
  • Male
  • Middle Aged
  • Mixed Function Oxygenases / genetics*
  • Polymorphism, Genetic*
  • Risk Factors
  • Spain

Substances

  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • Aryl Hydrocarbon Hydroxylases
  • CYP2A6 protein, human
  • Cytochrome P-450 CYP2A6